Skip to main content
. 2011 Dec 9;302(3):H837–H844. doi: 10.1152/ajpheart.00958.2011

Fig. 4.

Fig. 4.

ΔMAP (A) and ΔHR (B) caused by the intra-RVLM administration of acetaldehyde (2 μg) or an equal volume of aCSF (80 nl) in the absence and presence of the catalase inhibitor ATZ (10 mg/kg iv) in conscious SHRs. Values are means ± SE; numbers of rats in each group are shown in parentheses. *P < 0.05 vs. the respective saline + aCSF values; +P < 0.05 vs. the respective ATZ + acetaldehyde values; #P < 0.05 vs. the respective ATZ + aCSF values.